Get Avsola at BioHealth Infusion Center
About Avsola
Avsola (infliximab-axxq) is used to treat certain types of arthritis (Rheumatoid Arthritis (RA) and psoriatic arthritis), certain bowel diseases (Crohn’s disease and Ulcerative Colitis (UC)), as well as plaque psoriasis and ankylosing spondylitis (an inflammatory disease that, over time, can cause some of the bones in the spine to fuse).
In these inflammatory conditions, your immune system becomes overactive and produces excess amounts of a protein called TNF-alpha (tumor necrosis factor alpha), which causes your immune system to attack healthy cells. Avsola blocks the action of TNF-alpha, preventing inflammation.
Avsola is biosimilar to Remicade (Jannsen), the orginal forumlation of infliximab. Other Remicade biosimilars include Inflectra (Pfizer) and Renflexis (Merck).
Getting Your Avsola Infusion
Avsola is administered by intravenous infusion every eight weeks (every 6 weeks for ankylosing spondylitis) after an induction regimen that includes three doses over six weeks. Each infusion takes about two hours.
Your doctor may prescribe premedication with an antihistamine, acetaminophen, and/or corticosteroid along with your Avsola infusion.
Manufacturer:
First Approval:
Amgen
12/6/2019
Get Avsola at BioHealth Infusion Center and enjoy:
Perfect Medical Services
Schedule an Appointment
Our goal is to provide patients with courteous, prompt, and experienced infusion care. With just one phone call to the infusion center, the authorization process can begin immediately. All reimbursement and financial assistance options are explored in order to provide the patient’s infusion therapy at the lowest out-of-pocket costs to them.